Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Probiotics and prevention of Clostridium difficile infection.

Goldstein EJC, Johnson SJ, Maziade PJ, Evans CT, Sniffen JC, Millette M, McFarland LV.

Anaerobe. 2017 Jun;45:114-119. doi: 10.1016/j.anaerobe.2016.12.007. Epub 2016 Dec 14.

PMID:
27988389
2.

Pathway to Prevention of Nosocomial Clostridium difficile Infection.

Goldstein EJ, Johnson S, Maziade PJ, McFarland LV, Trick W, Dresser L, Millette M, Mazloum H, Low DE.

Clin Infect Dis. 2015 May 15;60 Suppl 2:S148-58. doi: 10.1093/cid/civ142.

PMID:
25922401
4.

Impact of adding prophylactic probiotics to a bundle of standard preventative measures for Clostridium difficile infections: enhanced and sustained decrease in the incidence and severity of infection at a community hospital.

Maziade PJ, Andriessen JA, Pereira P, Currie B, Goldstein EJ.

Curr Med Res Opin. 2013 Oct;29(10):1341-7. doi: 10.1185/03007995.2013.833501. Epub 2013 Aug 30.

PMID:
23931498
5.

Is primary prevention of Clostridium difficile infection possible with specific probiotics?

Johnson S, Maziade PJ, McFarland LV, Trick W, Donskey C, Currie B, Low DE, Goldstein EJ.

Int J Infect Dis. 2012 Nov;16(11):e786-92. doi: 10.1016/j.ijid.2012.06.005. Epub 2012 Aug 3. Review.

6.

Inhibitory Killer Immunoglobulin-like Receptors to self HLA-B and HLA-C ligands contribute differentially to Natural Killer cell functional potential in HIV infected slow progressors.

Kamya P, Tallon B, Melendez-Pena C, Parsons MS, Migueles SA, Connors M, Miconiatis S, Song R, Boulet S, Bruneau J, Tremblay CL, Bernard NF; investigators of the Canadian Cohort of HIV Infected Slow Progressors.

Clin Immunol. 2012 Jun;143(3):246-55. doi: 10.1016/j.clim.2012.01.001. Epub 2012 Jan 15.

PMID:
22445844
7.

Receptor-ligand requirements for increased NK cell polyfunctional potential in slow progressors infected with HIV-1 coexpressing KIR3DL1*h/*y and HLA-B*57.

Kamya P, Boulet S, Tsoukas CM, Routy JP, Thomas R, Côté P, Boulassel MR, Baril JG, Kovacs C, Migueles SA, Connors M, Suscovich TJ, Brander C, Tremblay CL, Bernard N; Canadian Cohort of HIV Infected Slow Progressors.

J Virol. 2011 Jun;85(12):5949-60. doi: 10.1128/JVI.02652-10. Epub 2011 Apr 6.

8.

Systematic patients' hand disinfection: impact on meticillin-resistant Staphylococcus aureus infection rates in a community hospital.

Gagné D, Bédard G, Maziade PJ.

J Hosp Infect. 2010 Aug;75(4):269-72. doi: 10.1016/j.jhin.2010.02.028. Epub 2010 Jun 18.

PMID:
20434796
9.

HIV infection affects blood myeloid dendritic cells after successful therapy and despite nonprogressing clinical disease.

Fontaine J, Coutlée F, Tremblay C, Routy JP, Poudrier J, Roger M; Montreal Primary HIV Infection and Long-Term Nonprogressor Study Groups.

J Infect Dis. 2009 Apr 1;199(7):1007-18. doi: 10.1086/597278.

PMID:
19231994
10.

Transmission networks of drug resistance acquired in primary/early stage HIV infection.

Brenner BG, Roger M, Moisi DD, Oliveira M, Hardy I, Turgel R, Charest H, Routy JP, Wainberg MA; Montreal PHI Cohort and HIV Prevention Study Groups.

AIDS. 2008 Nov 30;22(18):2509-15. doi: 10.1097/QAD.0b013e3283121c90.

Supplemental Content

Loading ...
Support Center